Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_assertion type Assertion NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_head.
- NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_assertion description "[Univariate analyses showed that lower OS and DFS rates were significantly associated with GCC and CK20 mRNA levels, the presence of lymph node metastases, the presence of mesenteric root lymph node metastases, and the presence of tumor emboli in vessels (p?<?0.05), but not with CEA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_provenance.
- NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_assertion evidence source_evidence_literature NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_provenance.
- NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_assertion SIO_000772 23150200 NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_provenance.
- NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_assertion wasDerivedFrom befree-20150227 NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_provenance.
- NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_assertion wasGeneratedBy ECO_0000203 NP911438.RAXfz3vG98HeVRCkfZYq_vikrXid3D-DiBRkLhTjLFKf8130_provenance.